MOZ, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.457
AS - Asia 2.401
EU - Europa 1.722
SA - Sud America 549
AF - Africa 416
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 38
AN - Antartide 1
Totale 11.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.166
SG - Singapore 760
CN - Cina 623
BR - Brasile 421
HK - Hong Kong 357
IT - Italia 290
PL - Polonia 205
FI - Finlandia 185
SE - Svezia 156
DE - Germania 147
VN - Vietnam 147
GB - Regno Unito 93
RU - Federazione Russa 85
FR - Francia 76
NL - Olanda 74
UA - Ucraina 50
CA - Canada 46
IN - India 42
MX - Messico 41
ID - Indonesia 31
KR - Corea 30
MY - Malesia 29
ZA - Sudafrica 27
AT - Austria 26
ES - Italia 25
IQ - Iraq 25
EC - Ecuador 21
JP - Giappone 21
PR - Porto Rico 21
DK - Danimarca 20
TR - Turchia 20
AR - Argentina 19
RO - Romania 19
SA - Arabia Saudita 19
BD - Bangladesh 18
BW - Botswana 18
CL - Cile 18
EG - Egitto 18
AU - Australia 17
BA - Bosnia-Erzegovina 17
CM - Camerun 16
EE - Estonia 16
GT - Guatemala 16
IE - Irlanda 16
IL - Israele 16
AZ - Azerbaigian 15
BB - Barbados 15
BE - Belgio 15
BG - Bulgaria 15
EU - Europa 15
GR - Grecia 15
IR - Iran 15
KZ - Kazakistan 15
NP - Nepal 15
AO - Angola 14
CI - Costa d'Avorio 14
CO - Colombia 14
CY - Cipro 14
CZ - Repubblica Ceca 14
GN - Guinea 14
PA - Panama 14
TZ - Tanzania 14
BZ - Belize 13
GF - Guiana Francese 13
HR - Croazia 13
JO - Giordania 13
KE - Kenya 13
LC - Santa Lucia 13
MD - Moldavia 13
MZ - Mozambico 13
TH - Thailandia 13
TT - Trinidad e Tobago 13
CV - Capo Verde 12
CW - ???statistics.table.value.countryCode.CW??? 12
GH - Ghana 12
HU - Ungheria 12
PT - Portogallo 12
PY - Paraguay 12
SK - Slovacchia (Repubblica Slovacca) 12
TW - Taiwan 12
UZ - Uzbekistan 12
ZM - Zambia 12
CR - Costa Rica 11
DM - Dominica 11
HT - Haiti 11
KG - Kirghizistan 11
LY - Libia 11
TN - Tunisia 11
UG - Uganda 11
AE - Emirati Arabi Uniti 10
BJ - Benin 10
CH - Svizzera 10
GA - Gabon 10
GE - Georgia 10
JM - Giamaica 10
LV - Lettonia 10
ME - Montenegro 10
MK - Macedonia 10
MU - Mauritius 10
PK - Pakistan 10
Totale 11.187
Salva come PNG Salva come JPEG
Città #
Fairfield 649
Woodbridge 611
Ann Arbor 573
Ashburn 570
Houston 536
Chandler 523
Singapore 477
Hong Kong 335
Cambridge 252
Wilmington 227
Seattle 222
Bytom 180
Boardman 152
Beijing 144
Jacksonville 139
Santa Clara 131
Princeton 114
Des Moines 111
Medford 101
Helsinki 82
Dong Ket 79
Padova 74
Los Angeles 70
Nanjing 68
San Diego 54
Roxbury 53
São Paulo 47
Buffalo 42
New York 35
Munich 33
Jinan 29
Redondo Beach 29
Shenyang 29
Ho Chi Minh City 27
Hebei 25
Guangzhou 22
Nanchang 21
Petaling Jaya 21
Changsha 19
Milan 19
London 18
Tianjin 17
Hefei 16
San Francisco 16
Chicago 15
Hanoi 15
Montreal 15
Zhengzhou 15
Bridgetown 14
Dallas 14
Jiaxing 14
Luanda 14
Stockholm 14
Baku 13
Conakry 13
Dublin 13
Gaborone 13
Johannesburg 13
Panama City 13
Phoenix 13
Shanghai 13
Abidjan 12
Amman 12
Brooklyn 12
Cairo 12
Castries 12
Dar es Salaam 12
Lusaka 12
Nowon-gu 12
Nuremberg 12
Rio de Janeiro 12
Vienna 12
Warsaw 12
Falkenstein 11
Kampala 11
Maputo 11
Praia 11
Tallinn 11
Tashkent 11
Toronto 11
Turku 11
Accra 10
Baghdad 10
Belo Horizonte 10
Cayenne 10
Cotonou 10
Kunming 10
Libreville 10
Limassol 10
Nairobi 10
Pune 10
Redwood City 10
Roseau 10
Sydney 10
Taizhou 10
Washington 10
Amsterdam 9
Curitiba 9
Dushanbe 9
Guatemala City 9
Totale 7.644
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 218
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 205
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 204
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 194
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 187
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 184
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 182
Emerging role of monocytes and of their intracellular calcium content in spondyloarthritis 172
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 169
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 161
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 158
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 157
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors 156
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 151
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 150
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 149
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 147
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 146
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 145
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 144
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 144
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 139
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 138
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFa therapy 135
VITAMIN D:FOE OF THE IMMUNE RESPONSE IN PANCREATIC CANCER 133
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 131
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 130
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 127
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 125
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 122
Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling 121
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 118
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 118
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 117
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 117
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 116
The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave 116
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 115
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 114
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 112
Vitamin D prevents pancreatic cancer-induced apoptosis signaling of inflammatory cells 112
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 111
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 110
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 108
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 107
Maldi-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and Complement C3. 106
Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study 106
NT-S100A8 effects on cell signalling. 105
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 105
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 104
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 104
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 104
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 104
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 102
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 101
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 101
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 100
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 99
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 97
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 96
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 96
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 95
Emerging role of monocytes and their intracellular calcium pattern in spondyloarthritis 95
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 94
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 94
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 93
Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer. 93
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 92
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 92
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 91
PRE-ANALYTICAL EFFECTS ON ESTABLISHED AND EMERGING BIOMARKERS OF CARDIOVASCULAR DISEASE (CVD) 90
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 89
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 89
New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance 88
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 87
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 87
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 87
Genome-wide association study identifies an early onset pancreatic cancer risk locus 86
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 85
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 85
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 83
The new commercial microarray inifiniti FMF test is feasible for the genetic diagnosis of familial mediterranean fever (FMF) in italian patients 82
Effectiveness of the combined evaluation of KLK3 genetics and f/tPSA ratio for prostate cancer diagnosis 82
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 81
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 81
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 81
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 79
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 77
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 77
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 75
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 74
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 74
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 71
The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-b1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling. 70
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 70
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 69
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 67
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 66
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 65
The inflammatory molecules S100A8 and TGF-b1 activate the epithelial-mesenchymal transition (EMT) process in pancreatic cancer (PaCa) cells 65
Totale 11.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.002
article - articoli 18.920
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021880 0 0 83 120 53 51 31 54 108 144 102 134
2021/2022998 14 173 68 56 36 77 28 98 55 11 94 288
2022/20231.116 203 107 13 129 194 159 10 76 148 9 38 30
2023/2024649 21 70 66 50 47 64 64 77 21 50 51 68
2024/20252.633 15 133 131 124 321 58 145 220 231 108 490 657
2025/20262.381 470 770 1.141 0 0 0 0 0 0 0 0 0
Totale 11.706